Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes.

Klampatsa A, O'Brien SM, Thompson JC, Rao AS, Stadanlick JE, Martinez MC, Liousia M, Cantu E, Cengel K, Moon EK, Singhal S, Eruslanov EB, Albelda SM.

Oncoimmunology. 2019 Jul 13;8(9):e1638211. doi: 10.1080/2162402X.2019.1638211. eCollection 2019.

PMID:
31428531
2.

Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer.

O'Brien SM, Klampatsa A, Thompson JC, Martinez MC, Hwang WT, Rao AS, Standalick JE, Kim S, Cantu E, Litzky LA, Singhal S, Eruslanov EB, Moon EK, Albelda SM.

Cancer Immunol Res. 2019 Jun;7(6):896-909. doi: 10.1158/2326-6066.CIR-18-0713. Epub 2019 May 3.

PMID:
31053597
3.

Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.

Singhal S, Stadanlick J, Annunziata MJ, Rao AS, Bhojnagarwala PS, O'Brien S, Moon EK, Cantu E, Danet-Desnoyers G, Ra HJ, Litzky L, Akimova T, Beier UH, Hancock WW, Albelda SM, Eruslanov EB.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaat1500. doi: 10.1126/scitranslmed.aat1500.

4.

Immune Checkpoint Ligand PD-L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis.

Maisel K, Merrilees MJ, Atochina-Vasserman EN, Lian L, Obraztsova K, Rue R, Vasserman AN, Zuo N, Angel LF, Gow AJ, Kang I, Wight TN, Eruslanov E, Swartz MA, Krymskaya VP.

Am J Respir Cell Mol Biol. 2018 Dec;59(6):723-732. doi: 10.1165/rcmb.2018-0123OC.

5.

Human neutrophils can mimic myeloid-derived suppressor cells (PMN-MDSC) and suppress microbead or lectin-induced T cell proliferation through artefactual mechanisms.

Negorev D, Beier UH, Zhang T, Quatromoni JG, Bhojnagarwala P, Albelda SM, Singhal S, Eruslanov E, Lohoff FW, Levine MH, Diamond JM, Christie JD, Hancock WW, Akimova T.

Sci Rep. 2018 Feb 16;8(1):3135. doi: 10.1038/s41598-018-21450-6.

6.

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients.

Bruno TC, Ebner PJ, Moore BL, Squalls OG, Waugh KA, Eruslanov EB, Singhal S, Mitchell JD, Franklin WA, Merrick DT, McCarter MD, Palmer BE, Kern JA, Slansky JE.

Cancer Immunol Res. 2017 Oct;5(10):898-907. doi: 10.1158/2326-6066.CIR-17-0075. Epub 2017 Aug 28.

7.

Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.

Akimova T, Zhang T, Negorev D, Singhal S, Stadanlick J, Rao A, Annunziata M, Levine MH, Beier UH, Diamond JM, Christie JD, Albelda SM, Eruslanov EB, Hancock WW.

JCI Insight. 2017 Aug 17;2(16). pii: 94075. doi: 10.1172/jci.insight.94075. eCollection 2017 Aug 17.

8.

Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Eruslanov EB, Singhal S, Albelda SM.

Trends Cancer. 2017 Feb;3(2):149-160. doi: 10.1016/j.trecan.2016.12.006. Epub 2017 Jan 19. Review.

9.

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.

Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, Malietzis G, Lee GH, Eruslanov E, Albelda SM, Wang X, Mehta JL, Bewtra M, Rustgi A, Hockstein N, Witt R, Masters G, Nam B, Smirnov D, Sepulveda MA, Gabrilovich DI.

Sci Immunol. 2016 Aug;1(2). pii: aaf8943. doi: 10.1126/sciimmunol.aaf8943. Epub 2016 Aug 5.

10.

Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer.

Eruslanov EB.

Cancer Immunol Immunother. 2017 Aug;66(8):997-1006. doi: 10.1007/s00262-017-1976-0. Epub 2017 Mar 10. Review.

11.

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells.

Stephen TL, Payne KK, Chaurio RA, Allegrezza MJ, Zhu H, Perez-Sanz J, Perales-Puchalt A, Nguyen JM, Vara-Ailor AE, Eruslanov EB, Borowsky ME, Zhang R, Laufer TM, Conejo-Garcia JR.

Immunity. 2017 Jan 17;46(1):51-64. doi: 10.1016/j.immuni.2016.12.015.

12.

Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis.

Allegrezza MJ, Rutkowski MR, Stephen TL, Svoronos N, Perales-Puchalt A, Nguyen JM, Payne KK, Singhal S, Eruslanov EB, Tchou J, Conejo-Garcia JR.

Cancer Res. 2016 Nov 1;76(21):6253-6265.

13.

Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.

Svoronos N, Perales-Puchalt A, Allegrezza MJ, Rutkowski MR, Payne KK, Tesone AJ, Nguyen JM, Curiel TJ, Cadungog MG, Singhal S, Eruslanov EB, Zhang P, Tchou J, Zhang R, Conejo-Garcia JR.

Cancer Discov. 2017 Jan;7(1):72-85. doi: 10.1158/2159-8290.CD-16-0502. Epub 2016 Sep 30.

14.

Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.

Singhal S, Bhojnagarwala PS, O'Brien S, Moon EK, Garfall AL, Rao AS, Quatromoni JG, Stephen TL, Litzky L, Deshpande C, Feldman MD, Hancock WW, Conejo-Garcia JR, Albelda SM, Eruslanov EB.

Cancer Cell. 2016 Jul 11;30(1):120-135. doi: 10.1016/j.ccell.2016.06.001. Epub 2016 Jun 30.

15.

Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer.

Moon EK, Ranganathan R, Eruslanov E, Kim S, Newick K, O'Brien S, Lo A, Liu X, Zhao Y, Albelda SM.

Clin Cancer Res. 2016 Jan 15;22(2):436-47. doi: 10.1158/1078-0432.CCR-15-1070. Epub 2015 Aug 31.

16.

CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.

Karakasheva TA, Waldron TJ, Eruslanov E, Kim SB, Lee JS, O'Brien S, Hicks PD, Basu D, Singhal S, Malavasi F, Rustgi AK.

Cancer Res. 2015 Oct 1;75(19):4074-85. doi: 10.1158/0008-5472.CAN-14-3639. Epub 2015 Aug 20.

17.

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, Akimova T, Vachani A, Litzky L, Hancock WW, Conejo-Garcia JR, Feldman M, Albelda SM, Singhal S.

J Clin Invest. 2014 Dec;124(12):5466-80. doi: 10.1172/JCI77053. Epub 2014 Nov 10.

18.

An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.

Quatromoni JG, Singhal S, Bhojnagarwala P, Hancock WW, Albelda SM, Eruslanov E.

J Leukoc Biol. 2015 Jan;97(1):201-9. doi: 10.1189/jlb.5TA0814-373. Epub 2014 Oct 30.

19.

Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammation.

Holt D, Okusanya O, Judy R, Venegas O, Jiang J, DeJesus E, Eruslanov E, Quatromoni J, Bhojnagarwala P, Deshpande C, Albelda S, Nie S, Singhal S.

PLoS One. 2014 Jul 29;9(7):e103342. doi: 10.1371/journal.pone.0103342. eCollection 2014.

20.

Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer.

Quatromoni JG, Predina JD, Bhojnagarwala P, Judy RP, Jiang J, De Jesus EM, Kapoor V, Cheng G, Okusanya OT, Eruslanov E, Singhal S.

J Immunother. 2014 Jun;37(5):283-92. doi: 10.1097/CJI.0000000000000038.

21.

Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3+ T-regulatory cells.

Akimova T, Xiao H, Liu Y, Bhatti TR, Jiao J, Eruslanov E, Singhal S, Wang L, Han R, Zacharia K, Hancock WW, Beier UH.

Mucosal Immunol. 2014 Sep;7(5):1209-20. doi: 10.1038/mi.2014.10. Epub 2014 Feb 19.

22.

Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17--a new mechanism of impaired antitumor immunity.

Mishalian I, Bayuh R, Eruslanov E, Michaeli J, Levy L, Zolotarov L, Singhal S, Albelda SM, Granot Z, Fridlender ZG.

Int J Cancer. 2014 Sep 1;135(5):1178-86. doi: 10.1002/ijc.28770. Epub 2014 Feb 27.

23.

The timing of TGF-β inhibition affects the generation of antigen-specific CD8+ T cells.

Quatromoni JG, Suzuki E, Okusanya O, Judy BF, Bhojnagarwala P, Venegas O, Eruslanov E, Predina JD, Albelda SM, Singhal S.

BMC Immunol. 2013 Jul 17;14:30. doi: 10.1186/1471-2172-14-30.

24.

Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas.

Eruslanov E, Stoffs T, Kim WJ, Daurkin I, Gilbert SM, Su LM, Vieweg J, Daaka Y, Kusmartsev S.

Clin Cancer Res. 2013 Apr 1;19(7):1670-80. doi: 10.1158/1078-0432.CCR-12-2091. Epub 2013 Jan 30.

25.

Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery.

Predina J, Eruslanov E, Judy B, Kapoor V, Cheng G, Wang LC, Sun J, Moon EK, Fridlender ZG, Albelda S, Singhal S.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):E415-24. doi: 10.1073/pnas.1211850110. Epub 2012 Dec 27.

26.

Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.

Quatromoni JG, Eruslanov E.

Am J Transl Res. 2012;4(4):376-89. Epub 2012 Oct 10.

27.

Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway.

Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM, Rosser CJ, Su LM, Vieweg J, Kusmartsev S.

Cancer Res. 2011 Oct 15;71(20):6400-9. doi: 10.1158/0008-5472.CAN-11-1261. Epub 2011 Sep 7.

28.

Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.

Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, Rosser C, Vieweg J, Gilbert SM, Kusmartsev S.

Int J Cancer. 2012 Mar 1;130(5):1109-19. doi: 10.1002/ijc.26123. Epub 2011 Jun 21.

29.

Aberrant PGE₂ metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.

Eruslanov E, Daurkin I, Vieweg J, Daaka Y, Kusmartsev S.

Int Immunopharmacol. 2011 Jul;11(7):848-55. doi: 10.1016/j.intimp.2011.01.033. Epub 2011 Feb 11.

30.

Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.

Eruslanov E, Daurkin I, Ortiz J, Vieweg J, Kusmartsev S.

J Leukoc Biol. 2010 Nov;88(5):839-48. doi: 10.1189/jlb.1209821. Epub 2010 Jun 29.

PMID:
20587738
31.

Identification of ROS using oxidized DCFDA and flow-cytometry.

Eruslanov E, Kusmartsev S.

Methods Mol Biol. 2010;594:57-72. doi: 10.1007/978-1-60761-411-1_4.

PMID:
20072909
32.

Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine.

Daurkin I, Eruslanov E, Vieweg J, Kusmartsev S.

Cancer Immunol Immunother. 2010 May;59(5):697-706. doi: 10.1007/s00262-009-0786-4. Epub 2009 Oct 31.

PMID:
19882154
33.

Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.

Porvasnik S, Sakamoto N, Kusmartsev S, Eruslanov E, Kim WJ, Cao W, Urbanek C, Wong D, Goodison S, Rosser CJ.

Prostate. 2009 Sep 15;69(13):1460-9. doi: 10.1002/pros.21008.

PMID:
19588526
34.

AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.

Glushakova LG, Lisankie MJ, Eruslanov EB, Ojano-Dirain C, Zolotukhin I, Liu C, Srivastava A, Stacpoole PW.

Mol Genet Metab. 2009 Nov;98(3):289-99. doi: 10.1016/j.ymgme.2009.05.010. Epub 2009 Jun 23.

35.

Altered expression of 15-hydroxyprostaglandin dehydrogenase in tumor-infiltrated CD11b myeloid cells: a mechanism for immune evasion in cancer.

Eruslanov E, Kaliberov S, Daurkin I, Kaliberova L, Buchsbaum D, Vieweg J, Kusmartsev S.

J Immunol. 2009 Jun 15;182(12):7548-57. doi: 10.4049/jimmunol.0802358.

36.

Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.

Sakai Y, Goodison S, Kusmartsev S, Fletcher B, Eruslanov E, Cao W, Porvasnik S, Namiki K, Anai S, Rosser CJ.

Prostate. 2009 Apr 1;69(5):459-70. doi: 10.1002/pros.20888.

PMID:
19107861
37.

Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma.

Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kübler H, Yancey D, Dahm P, Vieweg J.

Clin Cancer Res. 2008 Dec 15;14(24):8270-8. doi: 10.1158/1078-0432.CCR-08-0165.

38.

Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma.

Kusmartsev S, Eruslanov E, Kübler H, Tseng T, Sakai Y, Su Z, Kaliberov S, Heiser A, Rosser C, Dahm P, Siemann D, Vieweg J.

J Immunol. 2008 Jul 1;181(1):346-53.

39.

Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity.

Yan BS, Pichugin AV, Jobe O, Helming L, Eruslanov EB, Gutiérrez-Pabello JA, Rojas M, Shebzukhov YV, Kobzik L, Kramnik I.

J Immunol. 2007 Nov 15;179(10):6919-32.

40.

Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages.

Pan H, Mostoslavsky G, Eruslanov E, Kotton DN, Kramnik I.

J Immunol Methods. 2008 Jan 1;329(1-2):31-44. Epub 2007 Oct 18.

41.

Constitutive differences in gene expression profiles parallel genetic patterns of susceptibility to tuberculosis in mice.

Orlova MO, Majorov KB, Lyadova IV, Eruslanov EB, M'lan CE, Greenwood CM, Schurr E, Apt AS.

Infect Immun. 2006 Jun;74(6):3668-72.

42.

Analysis of cellular phenotypes that mediate genetic resistance to tuberculosis using a radiation bone marrow chimera approach.

Majorov KB, Eruslanov EB, Rubakova EI, Kondratieva TK, Apt AS.

Infect Immun. 2005 Sep;73(9):6174-8.

43.

Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice.

Eruslanov EB, Lyadova IV, Kondratieva TK, Majorov KB, Scheglov IV, Orlova MO, Apt AS.

Infect Immun. 2005 Mar;73(3):1744-53.

44.

Mycobacterial dissemination and cellular responses after 1-lobe restricted tuberculosis infection of genetically susceptible and resistant mice.

Mischenko VV, Kapina MA, Eruslanov EB, Kondratieva EV, Lyadova IV, Young DB, Apt AS.

J Infect Dis. 2004 Dec 15;190(12):2137-45. Epub 2004 Nov 15.

PMID:
15551212
45.

Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge.

Eruslanov EB, Majorov KB, Orlova MO, Mischenko VV, Kondratieva TK, Apt AS, Lyadova IV.

Clin Exp Immunol. 2004 Jan;135(1):19-28.

46.

Different innate ability of I/St and A/Sn mice to combat virulent Mycobacterium tuberculosis: phenotypes expressed in lung and extrapulmonary macrophages.

Majorov KB, Lyadova IV, Kondratieva TK, Eruslanov EB, Rubakova EI, Orlova MO, Mischenko VV, Apt AS.

Infect Immun. 2003 Feb;71(2):697-707.

47.

Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs.

Lyadova IV, Vordermeier HM, Eruslanov EB, Khaidukov SV, Apt AS, Hewinson RG.

Clin Exp Immunol. 2001 Nov;126(2):274-9.

48.

Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease.

Lyadova IV, Eruslanov EB, Khaidukov SV, Yeremeev VV, Majorov KB, Pichugin AV, Nikonenko BV, Kondratieva TK, Apt AS.

J Immunol. 2000 Nov 15;165(10):5921-31.

Supplemental Content

Loading ...
Support Center